IL17A and Chronic mucocutaneous candidosis: Chronic mucocutaneous candidiasis (CMC) has been observed in individuals with anti-IL-17A, anti-IL-17F, and anti-IL-22 autoantibodies, resulting from these autoantibodies blocking the Th-17 immunity (12).